Logo image of MTEX

MANNATECH INC (MTEX) Stock Fundamental Analysis

NASDAQ:MTEX - US5637712036 - Common Stock

9.1 USD
+0.25 (+2.82%)
Last: 8/28/2025, 8:27:43 PM
8.35 USD
-0.75 (-8.24%)
After Hours: 8/21/2025, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, MTEX scores 2 out of 10 in our fundamental rating. MTEX was compared to 35 industry peers in the Personal Care Products industry. MTEX has a bad profitability rating. Also its financial health evaluation is rather negative. MTEX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MTEX had negative earnings in the past year.
In the past year MTEX has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MTEX reported negative net income in multiple years.
In multiple years MTEX reported negative operating cash flow during the last 5 years.
MTEX Yearly Net Income VS EBIT VS OCF VS FCFMTEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.60%, MTEX is doing worse than 60.00% of the companies in the same industry.
MTEX has a Return On Equity (-2.90%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.6%
ROE -2.9%
ROIC N/A
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
MTEX Yearly ROA, ROE, ROICMTEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

MTEX's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of MTEX has declined.
MTEX has a better Gross Margin (76.58%) than 88.57% of its industry peers.
In the last couple of years the Gross Margin of MTEX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MTEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.58%
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
MTEX Yearly Profit, Operating, Gross MarginsMTEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

MTEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MTEX has been increased compared to 1 year ago.
Compared to 5 years ago, MTEX has less shares outstanding
The debt/assets ratio for MTEX is higher compared to a year ago.
MTEX Yearly Shares OutstandingMTEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
MTEX Yearly Total Debt VS Total AssetsMTEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

MTEX has an Altman-Z score of 3.59. This indicates that MTEX is financially healthy and has little risk of bankruptcy at the moment.
MTEX has a Altman-Z score (3.59) which is in line with its industry peers.
MTEX has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.46, MTEX is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 3.59
ROIC/WACCN/A
WACC9.26%
MTEX Yearly LT Debt VS Equity VS FCFMTEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.18 indicates that MTEX should not have too much problems paying its short term obligations.
MTEX has a worse Current ratio (1.18) than 65.71% of its industry peers.
MTEX has a Quick Ratio of 1.18. This is a bad value and indicates that MTEX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.65, MTEX is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.65
MTEX Yearly Current Assets VS Current LiabilitesMTEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

MTEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.77%, which is quite impressive.
MTEX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.73% yearly.
The Revenue has decreased by -9.62% in the past year.
The Revenue has been decreasing by -5.66% on average over the past years.
EPS 1Y (TTM)87.77%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-228.5%
Revenue 1Y (TTM)-9.62%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-9.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTEX Yearly Revenue VS EstimatesMTEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MTEX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTEX Price Earnings VS Forward Price EarningsMTEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTEX is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.91
MTEX Per share dataMTEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.83%, MTEX is a good candidate for dividend investing.
MTEX's Dividend Yield is rather good when compared to the industry average which is at 5.54. MTEX pays more dividend than 94.29% of the companies in the same industry.
MTEX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 8.83%

5.2 History

MTEX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MTEX Yearly Dividends per shareMTEX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
MTEX Yearly Income VS Free CF VS DividendMTEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

More info and screens

MANNATECH INC

NASDAQ:MTEX (8/28/2025, 8:27:43 PM)

After market: 8.35 -0.75 (-8.24%)

9.1

+0.25 (+2.82%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-10 2025-11-10
Inst Owners18.93%
Inst Owner Change0.14%
Ins Owners44.9%
Ins Owner Change0%
Market Cap17.29M
Analysts0
Price TargetN/A
Short Float %1.02%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 8.83%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 2.28
P/tB 2.28
EV/EBITDA 9.91
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS60.55
BVpS3.99
TBVpS3.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -2.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.58%
FCFM N/A
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
F-Score3
Asset Turnover3.14
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA 2.96
Cap/Depr 51.38%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.65
Altman-Z 3.59
F-Score3
WACC9.26%
ROIC/WACCN/A
Cap/Depr(3y)43.45%
Cap/Depr(5y)43.17%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.77%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-228.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.62%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-9.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y74.29%
EBIT growth 3Y-45.85%
EBIT growth 5Y-25.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.07%
FCF growth 3Y-42.1%
FCF growth 5Y-11.9%
OCF growth 1Y46.39%
OCF growth 3Y-40.57%
OCF growth 5Y-14.4%